Akt Inhibitor MK2206 Selectively Targets CLL B-cell Receptor Induced Cytokines, Mobilizes Lymphocytes and Synergizes with Bendamustine to Induce CLL Apoptosis
- Citation:
- Br J Haematol vol 164 (1) 146-150
- Year:
- 2014
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- 1039 is parent abstract
- Pharmas:
- Grants:
- K23 CA160345, R01 CA095241, CA95241, K23CA160345
- Corr. Author:
- Authors:
- Wei Ding Tait D. Shanafelt Connie E. Lesnick Charles Erlichman Jose F. Leis Charla Secreto Traci R. Sassoon Timothy G. Call Deborah A. Bowen Michael Conte Shaji Kumar Neil E. Kay
- Networks:
- Study
- NCCTG-N1087
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1/2
- Keywords:
- chronic lymphocytic leukaemia, Akt, B cell receptor, cytokine